News
A stroke drug called GAI-17 protected mouse brains even six hours after damage began—and may one day help fight Alzheimer’s ...
Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...
We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics ...
A new drug could one day revolutionize how stroke patients are treated by preventing further damage to the brain. Each year, some 795,000 people in the United States experience a stroke, the CDC ...
Stroke kills millions, but Osaka researchers have unveiled GAI-17, a drug that halts toxic GAPDH clumping, slashes brain ...
Days after JCR Pharmaceuticals signed a deal with AstraZeneca’s rare disease unit, the Japanese biopharma has secured a ...
Background Evidence on preventing Alzheimer’s disease (AD) is challenging to interpret due to varying study designs with heterogeneous endpoints and credibility. We completed a systematic review and ...
Massive proteomics database links gene variant APOE 4 to chronic inflammation.
Rural hospitals have been closing, putting emergency care further out of reach, but that’s only one of the heightened ...
A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...
This research suggests that early menopause may itself be a direct risk factor for cognitive decline, even when depression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results